Chronic kidney disease among high school students of Kinshasa

  • Justine B Bukabau1,

    Affiliated with

    • Jean-Robert R Makulo1,

      Affiliated with

      • Nestor M Pakasa3,

        Affiliated with

        • Eric P Cohen4,

          Affiliated with

          • François B Lepira1,

            Affiliated with

            • Patrick K Kayembe2,

              Affiliated with

              • Nazaire M Nseka1 and

                Affiliated with

                • Ernest K Sumaili1Email author

                  Affiliated with

                  BMC Nephrology201213:24

                  DOI: 10.1186/1471-2369-13-24

                  Received: 28 May 2011

                  Accepted: 4 May 2012

                  Published: 4 May 2012



                  Chronic kidney disease (CKD) is a major worldwide health problem. However, its burden among adolescents and young adults is unknown, especially in sub-Saharan Africa. The aim of this study was to investigate its prevalence in the school environment. The concordance of usual formulas used to estimate renal function was also assessed.


                  In an epidemiological cross sectional study, a random sample of 524 pupils (263 boys, mean age of 18.7 ± 1.4 years) from school environment of Kinshasa were studied. Recorded parameters of interest were anthropometric, proteinuria, serum creatinine and estimated glomerular filtration rate (eGFR) according to the Schwartz formula using uncalibrated creatinine levels from one random measurement. CKD was defined as the presence of kidney damage (daily proteinuria ≥ 300 mg) and/or reduced kidney function (eGFR < 60 ml/min/1.73 m2). Concordances between eGFR according to Schwartz, Cockcroft-Gault (C-G) indexed for BSA and modification of diet in renal disease (MDRD) study equations were computed using the kappa coefficient.


                  The prevalence of CKD by the Schwartz formula was 1.5%. By stage, 0.8% had CKD stage 1 (proteinuria with normal eGFR) and 0.8% had CKD stage 3 (eGFR, 30 to 59 ml/min/1.73 m2). The prevalence of proteinuria ≥ 300 mg/day was 1% (one case had 2.7g/day). Agreement between eGFR according to Schwartz formula and the MDRD formula was excellent (kappa: 88.8%). Although correlations between all formulas were excellent (0.99; 0.87, and 0.89), agreement was poor between eGFR according to Schwartz and C-G indexed BSA equation (kappa: 52.7%) and, poorer with C-G unadjusted for BSA (kappa: 26.9%).


                  In the large African city of Kinshasa, 2% of high school students have CKD. This high prevalence rate emphasizes the need for appropriate detection and prevention measures in this vulnerable young age population group.


                  Equation of reduced renal function CKD High school students Prevalence Kinshasa


                  Chronic kidney disease (CKD) is a worldwide public health concern [1]. Epidemiological studies in both western and developing countries have reported an increase of its incidence and prevalence in recent years [1, 2]. People with CKD may develop cardiovascular illness more often than unaffected general population, and may also progress to end stage renal disease (ESRD) [3]. At that late stage, management requires dialysis or kidney transplantation which are extremely expensive, over 30 billion dollars yearly in the United States [4]. The cost of ESRD accounts for 0.7% and 1.8% of the English and Belgian health budgets, respectively [5].

                  Thus, prevention and early detection of CKD have been advised in many guidelines [6]. Early detection can be effective in developed countries, but it is problematic in developing one’s like the Democratic Republic of Congo (DRC) where recent reports have shown that majority of patients are only detected at late stages [7]. Indeed, about 75% CKD patients admitted to the Renal Unit of the University Hospital of Kinshasa are at stages 4 and 5 of kidney disease [8].

                  In children, CKD is frequently due to congenital malformations of the kidneys and the urinary tract, and inherited disorders [9]. Glomerulonephritis due to infections is a major cause of CKD in Africa [10]. However, paucity of renal symptoms and signs in early stages of CKD hinders their early detection. The tests performed to detect CKD at early stage are urinalysis, proteinuria, calculated creatinine clearance or estimated glomerular filtration rate (eGFR) and imaging of the renal parenchyma and urinary tract [11]. The GFR is a useful tool to assess the progression of CKD. However, the precise measurement of GFR is invasive, time-consuming, expensive and technically difficult to perform, especially in children and adolescents. To bypass these constraints, the Schwartz formula has been recommended to estimate GFR in children and adolescents [12]. In routine practice, pediatricians often do use Cockcroft-Gault (CG) or Modification of Diet in Renal Disease (MDRD) formulas instead of the Schwartz formula, especially for adolescents [13, 14].

                  In Congolese HIV-infected children (median age 7 years), the prevalence of proteinuria is reported to be of 23.8% [15]. However, knowledge of CKD among non-HIV-infected young Congolese is limited. In order to ascertain the burden of CKD in Congolese children, the present study was designed to determine the prevalence of CKD among adolescents and young adults in the school environment of Kinshasa. The agreement between Schwartz, CG and MDRD formulas was also tested.


                  In this cross sectional study, a sample of 524 secondary school students was randomly selected according to a multistage sampling. The units of the survey were: East of the city of Kinshasa (first degree), urban districts (second degree) and schools (third degree). A total of six schools were visited. The proportions of participants varied according to the class of school.

                  Students were examined by the research team, who recorded demographic parameters (age and sex), body weight, height and waist circumference. The body mass index (BMI) was calculated from the measured weight (in kilograms) and height (in meters) and was categorized as not obese (< 25 kg/m2), overweight (25–29, 9 kg/m2) or obese (≥ 30 kg/m2) according to the WHO 2000 criteria [16]. Blood pressure was measured three times in a sitting position, in the right or left arm, at the heart level, using a calibrated aneroid sphygmomanometer. All students could relax for 5 minutes before determination of blood pressure and an average of three blood pressure measurements was used. Hypertension (HTN) was defined as systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg and/or concomitant use of antihypertensive medications by self-report.

                  We collected a 5 ml blood sample for serum creatinine measurement using the Jaffe compensated method. The GFR was estimated by Schwartz formula and compared to the CG equation normalized per 1.73 m2 of BSA and to the MDRD Study formula.

                  The participants provided a urine sample to detect protein by test strips (Albustix). Female subjects were instructed to void a random urine specimen, remote from menstrual periods. Results were expressed as negative, 1+, 2+ or 3+. Twenty-four quantitative proteinuria was measured by Esbach method if proteinuria by dipstick was positive. All measurements of serum creatinine and daily proteinuria were performed in the laboratory of the Belgian medical center of Kinshasa ‘CMK’.

                  In that present study, proteinuria was defined as a positive reaction to the Albustix test (≥ 1+ albumin equivalent to ≥ 30 mg/dl) which was confirmed by a quantitative proteinuria ≥ 300mg/day.

                  The Kidney disease improving global outcome (KDIGO) guidelines [6] for definition and classification of CKD were used. CKD all stages was defined as the presence of quantitative daily proteinuria ≥ 300mg and/or an eGFR < 60 ml/min/1.73 m2. In brief, CKD stages are defined as follows: stage 1, proteinuria ≥ 300 mg per day with an eGFR ≥ 90 mL/min/1.73 m2; stage 2, proteinuria ≥ 300 mg/day with an eGFR of 60–89 mL/min/1.73 m2; stage 3, an eGFR of 30–59 mL/min/1.73 m2, stage 4, an eGFR of 15–29 mL/min/1.73 m2 and stage 5, an eGFR < 15 mL/min/1.73 m2.

                  Schwartz equation

                  [K × height in centimeters]/[serum creatinine level in mg/L]. For this study, K was 0.55 and 0.7 for adolescent girls and adolescent boys respectively [17].

                  CG equation

                  [(140-age in years) × weight in kilograms]/[72× serum creatinine level in mg/dL], with use of the 0.850 multiplier for female gender [13]. Predictions by CG equation were also normalized per 1.73 m2 of body surface area (BSA) for comparison to the other equations. BSA (m2) was calculated as √ height (cm) × weight (Kg)/3600 [18].

                  MDRD study equation

                  186 × serum creatinine level [mg/dL]-1,154 × age [years] -0,203. For women and blacks, the product of this equation is multiplied by correction factors of 0.742 and 1.21 respectively) [14]. The equation was used without creatinine assay calibration. Thus, the MDRD formula predictions could be biased by to differences in the creatinine assay between the MDRD laboratory and our laboratory [19].

                  Statistical analysis

                  All data were processed using a standard statistical package (SPSS version 10.05, 2004). The results are presented as means ± standard deviations, and/or proportions. To compare groups, we used the Chi-square test for qualitative variables and Student t test for quantitative variables. The agreement between the eGFR by Schwartz versus CG standardized BSA and MDRD equations were assessed by the kappa coefficient. A p value < 0.05 indicated statistical significance.

                  All participants provided informed written consent. This study was approved by the Ethics committee of the Public Health of the University of Kinshasa and the relevant political, administrative and school authorities.


                  Characteristics of the study population

                  The general characteristics of the entire group are summarized in Table 1. Girls had higher BMI and waist circumference than boys.
                  Table 1

                  Characteristics of the population


                  Whole Group N = 524

                  Males N = 263

                  Females N = 261


                  Age, years ± SD

                  18.7 ± 1.4

                  18.7 ± 1.4

                  18.6 ± 1.4


                  Weight, Kg ± SD

                  55.4 ± 8.2

                  57.8 ± 7.7

                  52.9 ± 7.9


                  Height, cm ± SD

                  167.1 ± 8.9

                  172.8 ± 7.3

                  161.4 ± 6.4


                  BMI, Kg/m2 ± SD

                  19.8 ± 0.4

                  19.3 ± 2.1

                  20.2 ± 2.7


                  BMI 25–29 Kg/m2, n (%)

                  15 (2.9)

                  3 (1.1)

                  12 (4.6)


                  BMI ≥ 30 Kg/m2, n (%)

                  5 (0.9)

                  0 (0)

                  5 (1.9)


                  Waist circumference, cm ± SD

                  78.5 ± 11,3

                  73.9 ± 9.8

                  83.3 ± 10.5


                  SBP, mmHg ± SD

                  107.3 ± 11.3

                  108.1 ± 11.7

                  106.5 ± 10.8


                  DBP, mmHg ± SD

                  70.9 ± 8.1

                  71.7 ± 8.2

                  70.1 ± 7.9


                  HTN, %

                  16 (3.1)

                  10 (3.8)

                  6 (2.3)


                  Values expressed as numbers and proportions (%) in parentheses ± SD, as appropriate.

                  Abbreviations: HTN = hypertension, SD = standard deviation, SBP = systolic blood pressure, DBP = diastolic blood pressure. BMI = body mass index; ns = no significant.

                  Prevalence of CKD

                  Table 2 shows the prevalence of CKD in secondary school students of Kinshasa. Depending on the method used to estimate the eGFR, 1.5%, 1.7%, 2.9% and 7.6% had CKD according to the Schwartz, MDRD, CG indexed BSA and CG formulas, respectively. No subjects were found at later CKD stages 4 and 5.
                  Table 2

                  Prevalence of CKD in high school students of Kinshasa




                  CG indexed BSA



                  mL/min/ 1.73 m2

                  mL/min/ 1.73 m2

                  mL/min/ 1.73 m2



                  4 (0.8)


                  2 (0.4)

                  2 (0.4)




                  3 (0.6)

                  3 (0.6)




                  10 (1.9)

                  35 (6.7)











                  All stage

                  8 (1.5)

                  9 (1.7)

                  15 (2.9)

                  40 (7.6)

                  Values expressed as numbers and proportions (%) in parentheses.

                  CKD is defined as either kidney damage (proteinuria ≥ 300 mg/day) and/or kidney function (< 60ml/min/1.73 m2). KDIGO CKD stages are defined as follows: stage 1, proteinuria ≥ 300 mg per day with an eGFR ≥ 90 mL/min/1.73 m2; stage 2, proteinuria ≥ 300 mg/day with an eGFR of 60–89 mL/min/1.73 m2; stage 3, an eGFR of 30–59 mL/min/1.73 m2, stage 4, an eGFR of 15–29 mL/min/1.73 m2 and stage 5, an eGFR < 15 mL/min/1.73 m2.

                  The prevalence of proteinuria by dipstick was 7.4% (39 students). Only five students (1.0%) had proteinuria ≥ 300 mg/day, and the amounts of this proteinuria were 370, 400, 490, 1050 and 2700 mg. By multivariate logistic regression analysis we found no association between proteinuria or reduced kidney function and risk factors such as hypertension, diabetes and obesity.

                  Indicators of renal function by Schwartz equation

                  The indicators of renal function are shown in Table 3. Girls had average serum creatinine levels higher than that recorded in boys.
                  Table 3

                  Indicators of renal function according to the Schwartz formula in high school students from Kinshasa


                  Whole groupN = 524

                  Males N = 263

                  Females N = 261

                  P value

                  S. creatinine, mg/dL ± SD

                  0.92 ± 0.20

                  0.87 ± 0.16

                  0.96 ± 0.21


                  eGFR, mL/min/1.73 m2 ± SD

                  119.13 ± 33.02

                  143.75 ± 24.87

                  96.32 ± 21.08


                  eGFR ≥ 90 mL/min/1.73 m2, %





                  eGFR 60–89 mL/min/1.73 m2, %





                  eGFR < 60 mL/min/1.73 m2, %





                  Values are proportions or mean ± SD, as appropriate. SD = standard deviation.

                  Comparison between Schwartz formula, CG indexed BSA and MDRD study equations

                  Figure 1 compares the eGFR by Schwartz versus CG indexed BSA and MDRD study. By grouping together the pupils with regard to their eGFR, the results obtained with the Schwartz formula were close to those obtained by MDRD study equation.
                  Figure 1

                  Comparison of eGFR between Schwartz versus MDRD study, CG indexed BSA and CG unadjusted for BSA.

                  The linear correlation was excellent between Schwartz vs MDRD formula (r = 0.99), Schwartz vs CG indexed BSA (r = 0.87) and for Schwartz vs CG formula not indexed to BSA (r = 0.89). However, the concordance between Schwartz, CG indexed BSA and MDRD study formulas to define eGFR < 60 ml/min/1.73 m2, according to kappa statistics showed very good agreement only between Schwartz and MDRD (kappa = 0. 88) (Table 4).
                  Table 4

                  Correlation of eGFR < 60 ml/min/1.73 m 2 based on different equations and agreement between formulas






                  MDRD study equation



                  CG indexed BSA



                  CG formula



                  MDRD: Modification of Diet in Renal Disease CG: Cockcroft - Gault.


                  Our study documents for the first time the burden of CKD based on KDIGO guidelines in presumed healthy high school students in Kinshasa. We show that CKD affects Congolese people at school age. The overall prevalence of CKD in this population varies between 1.5-2.9% depending on the method used to estimate GFR. The difference observed in the prevalence of CKD according to Schwartz versus CG equations may derive from the body weight measurement, a variable that is not included in the Schwartz formula [12]. Thus, relative lower body weight in school children may explain some of higher prevalence of CKD stage 3 according to the CG formula. Hence, we considered only the results based on Schwartz formula. Based on this method, 1.5% of pupils are affected by all stages of CKD. This finding is eight times less than the 13% prevalence of CKD yielded in American adults [20] and is also much less than the 12.4% previously recorded in adult general population from Kinshasa [2]. However, it is similar to the prevalence of 1.4% in the age group between 20 and 39 years [2], regardless of the time of study and the formula used to estimate GFR (uncalibrated versus calibrated serum creatinine).

                  Nearly 1% of this pediatric population had CKD stage 3. This result is lower than that of 1.7% recorded among children in Mexico [21]. Comparisons between studies are difficult as the definitions and the criteria of selection may differ. Although the present study did not address the specific etiology of CKD, none of the subjects at CKD stage 3 had hypertension, diabetes or obesity. Possible causes could include genetic or acquired kidney disease.

                  At a similar age in this survey, girls had an average serum creatinine levels higher than that of boys, which corresponded to an average of lower eGFR. The reason for this discrepancy remains unclear, but might due to differences in sexual maturity and activity. Indeed, Congolese girls reach sexual maturity and activity earlier than Congolese boys [22]. It is likely that some girls in our survey were sexually active, a fact that could account for higher relative muscle mass and/or even HIV infection. Moreover, HIV prevalence is higher among young women than in young men [23, 24]. It is also known that young women have a great susceptibility to HIV infection than men [24]. By contrast, the higher BMI observed in females, which is likely mainly driven by fat, but not muscle, should not contribute to higher serum creatinine levels. However, this study did not address the specific causes of lower eGFR in individual subjects.

                  Another important finding in this present study is the excellent agreement between both Schwartz versus MDRD study equations contrary to CG in the age ranges of 16 to 24 years. To the best our knowledge, these equations have not been validated in African populations. That good concordance found from 16 years old could be explained by the fact that both formulas do not consider the weight. Consequently, in the absence of a reference test, the MDRD or Schwartz formulas are useful tools for the estimation of GFR in adolescents. More structured studies comparing the MDRD study equation to a reference test such as Inulin, Iothalamate or Iohexol could be conducted to validate their correspondence to the real GFR. But, such expensive testing may not be very helpful. Also, the accuracy of GFR estimating equations is known to be highly dependent on creatinine assay, which should be calibrated with that of the MDRD laboratory for use in the MDRD study equation [19] as well as for the more recent new equations for children [25] and the CKD-EPI equation for adults > 18 years [26]. Thus, many centers in industrialized countries move towards enzymatic creatinine, which yield lower creatinine values. This is not the case in many low income countries like the DRC, where many laboratories still use the Jaffe method. Consequently, the new equations are not appropriate for us. Hence, our option to use older equations appears justified and relevant for some low resourced countries.

                  Obesity and hypertension were infrequent among the students in this study. The prevalence of 0.9% of obesity is similar to the data reported by Kane et al. in Senegal [27]. Despite of the ‘epidemiological transition’, the low prevalence of obesity in developing countries can be explained by the fact that adolescents and young adults still face economic burden, political, cultural and religious upheavals’ different from those encountered in developed countries. The prevalence of 3.1% for hypertension is consistent with results from previous results observed in schools of Kinshasa, which ranged between 1.4 to 5% [28].

                  Our observations show that prevalence of qualitative and quantitative proteinuria was 7.4% versus 1%, respectively. We found one case of quantitative proteinuria of 2.7 grams/day. Some cases with qualitative proteinuria could just be intermittent as during orthostatic proteinuria frequently reported in children and adolescents. Studies in North America, Europe and Asia have shown that prevalence of proteinuria in children varies according to the methodology used. This may have important implications for the cost effectiveness and viability of a screening program [29].

                  This study had some limitations that must be acknowledged when interpreting the results. Although all positive dipstick proteinuria (qualitative) tests were supplemented by quantitative daily proteinuria as an indicator of kidney damage, only one single measurement was done. Studies based on NHANES III indicate that in repeated measurement, only 63% of those with albuminuria will have persistently positive results [20]. In KDIGO guidelines [6], the definition of CKD requires the persistence of kidney damage for at least 3 months. Hence, the single measurement of proteinuria, serum creatinine or BP in our study, might overestimate the prevalence of CKD and HTN.

                  On the other hand, the prevalence of CKD may have been underestimated because urinalysis was not done to detect hematuria and renal imaging was not routinely performed.


                  Our study establishes that roughly 2% of high-school students in Kinshasa have proteinuria and/or estimated GFR < 60 ml/min. There is a good agreement between eGFR by Schwartz versus MDRD study equation in our target population. This high prevalence appeals for awareness and action like systematic screening for CKD to alleviate the burden of CKD in the schools and the identification of preventable risk factors specific to this age group in order to address and slow down the progression to ESRD.



                  This work was supported by the Belgian medical center of Kinshasa ‘’CMK”. We are indebted to Mukiese JM, Mabasa Y and Sadiki for their involvement. We thank the staff of laboratory of medical center of Kinshasa and Alfred Loka MD for reviewing the manuscript.

                  Authors’ Affiliations

                  Democratic Republic of Congo (DRC), Nephrology Unit, University of Kinshasa
                  Democratic Republic of Congo School of Public Health, University of Kinshasa
                  Democratic Republic of Congo (DRC) Department of pathology, University of Kinshasa
                  Nephrology Division, Medical College of Wisconsin


                  1. Meguid El Nahas A, Bello AK: Chronic kidney disease: the global challenge. Lancet 2005,365(9456):331–340.PubMedView Article
                  2. Sumaili EK, Krzesinski JM, Zinga CV, Cohen EP, Delanaye P, Munyanga SM, Nseka NM: Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant 2009,24(1):117–122.PubMedView Article
                  3. Martins D, Ani C, Pan D, Ogunyemi O, Norris K: Renal dysfunction, metabolic syndrome and cardiovascular disease mortality. J Nut Metab 2010, 10.1155:.
                  4. Anonymous : USRDS: the United States Renal Data System. Am J Kidney Dis 2003,42(6 Suppl 5):1–230.
                  5. De Vecchi AF, Dratwa M, Wiedemann ME: Healthcare systems and end-stage renal disease (ESRD) therapies–an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999,14(Suppl 6):31–41.PubMedView Article
                  6. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, et al.: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007,72(3):247–259.PubMedView Article
                  7. Sumaili EK, Cohen EP, Zinga CV, Krzesinski JM, Pakasa NM, Nseka NM: High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol 2009, 10:18.PubMedView Article
                  8. Krzesinski JM, Sumaili KE, Cohen E: How to tackle the avalanche of chronic kidney disease in sub-Saharan Africa: the situation in the Democratic Republic of Congo as an example. Nephrol Dial Transplant 2007,22(2):332–335.PubMedView Article
                  9. Nigel I, Orr Stephen P, McDonald SP, McTaggart P, Henning JCC: Frequency, etiology and treatement of childhood end-stage kidney disease in Australia and New Zealand. Pediatr Nephrol 2009, 24:1719–1726.View Article
                  10. Pakasa NM, Sumaili EK: The nephrotic syndrome in the Democratic Republic of Congo. N Engl J Med 2006,354(10):1085–1086.PubMedView Article
                  11. Hellinger JC, Medina LS, Epelman M: Pediatric advanced imaging and informatics: state of the art. Semin Ultrasound CT MR 2010,31(2):171–193.PubMedView Article
                  12. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976,58(2):259–263.PubMed
                  13. Cockcroft D, Gault H: Prediction of creatinine clearance from serum creatinine. Nephron 1976,16(1):31–41.PubMedView Article
                  14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999,130(6):461–470.PubMed
                  15. Ekulu PM, Nseka NM, Aloni MN, Gini JL, Makulo JR, Lepira FB, Sumaili EK, Mafuta EM, Nsibu CN, Shiku JD: Prevalence of proteinuria and its association with HIV/AIDS in Congolese children living in Kinshasa, Democratic Republic of Congo.[Article in French]. Nephrol Ther 2011,:.
                  16. WHO: Report series 894. In The problem of overweight and obesity: preventing and managing the global epidemic. WHO, Geneva; 2000:537.
                  17. Brucker ME, Krummel T, Bazin D, Hannedouche T: Early diagnosis of renal failure. Nephrol Ther 2007,3(S4):195–200.
                  18. Mosteller RD: Simplified calculation of body-surface area. N Engl J Med 1987,317(17):1098.PubMed
                  19. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS: Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002,39(5):920–929.PubMedView Article
                  20. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003,41(1):1–12.PubMedView Article
                  21. Koshy S, Garcia-Garcia G, Pamplona J, Renoirte-Lopez K, Perez-Cortes G, Gutierrez M, Hemmelgarn B, Lloyd A, Tonelli M: Screening for kidney disease in children on World Kidney Day in Jalisco, Mexico. Pediatr Nephrol 2009,24(6):1219–1225.PubMedView Article
                  22. Anonymous: Ministry of Planning & Ministry of Health of Democratic Republic of Congo: Demographic and Health Survey 2007 (EDS-RDC), Final report. 2011. Available at: htpp:// ; 2011. Accessed December 2
                  23. Lydie N, Robinson NJ, Ferry B, Akam E, De Loenzien M, Zekeng L, Abega S: Adolescent sexuality and the HIV epidemic in Yaounde, Cameroon. J Biosoc Sci 2004,36(5):597–616.PubMedView Article
                  24. Kelly RJ, Gray RH, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Wawer MJ: Age differences in sexual partners and risk of HIV-1 infection in rural Uganda. J Acquir Immune Defic Syndr 2003,32(4):446–451.PubMedView Article
                  25. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL: New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009,20(3):629–637.PubMedView Article
                  26. Levey AS, Stevens LA, Schmid CH, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al.: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009,150(9)):604–612.PubMed
                  27. Kane A, Ly M, Sarr M, Diouf ND, Dia AA, Diop PS, Diao M, Diop AK, Diop IB, Hane L, et al.: Arterial pressure and body mass index of children and adolescents in a rural area of Thiadiaye, Senegal. Dakar Med 1998,43(1):83–89.PubMed
                  28. Tshiani KA, Nseka M, Musuamba M, Lutete K: Epidemiologie de l`hypertension artérielle au Zaire (résultats d’une enquête préliminaire chez 4988 sujets). Méd Afr Noire 1979, 26:67–75.
                  29. Haysom L, Williams R, Hodson E, Lopez-Vargas P, Roy L, Lyle D, Craig J: Cardiovascular risk factors in Australian indigenous and non-indigenous children: a population-based study. J Paediatr Child Health 2009,45(1–2):20–27.PubMedView Article
                  30. Pre-publication history

                    1. The pre-publication history for this paper can be accessed here:http://​www.​biomedcentral.​com/​1471-2369/​13/​24/​prepub


                  © Bukabau et al.; licensee BioMed Central Ltd. 2012